PPADS and suramin as antagonists at cloned P-2Y- and P-2U-purinoceptors

被引:133
作者
Charlton, SJ
Brown, CA
Weisman, GA
Turner, JT
Erb, L
Boarder, MR
机构
[1] UNIV LEICESTER,DEPT CELL PHYSIOL & PHARMACOL,LEICESTER LE1 9HN,LEICS,ENGLAND
[2] UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65212
[3] UNIV MISSOURI,DEPT PHARMACOL,COLUMBIA,MO 65212
基金
英国惠康基金;
关键词
P-2Y-purinoceptors; P-2U-purinoceptors; ectonucleotidases; suramin; PPADS;
D O I
10.1111/j.1476-5381.1996.tb15457.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of suramin and pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) on the stimulation of phospholipase C in 1321N1 cells transfected with the P-2U-purinoceptor (h-P-2U-1321N1 cells) or with the turkey P-2Y-purinoceptor (t-P-2Y-1321N1 cells) was investigated. 2-methylthioadenosine triphosphate (2MeSATP) was used as the agonist at t-P-2Y-1321N1 cells and uridine triphosphate (UTP) at h-P-2U-1321N1 cells. 2 Suramin caused a parallel shift to the right of the concentration-response curves for 2MeSATP in the t-P-2Y-1321N1 cells, yielding a Schild plot with a slope of 1.16+/-0.08 and a pA(2) value of 5.77+/-0.11. 3 Suramin also caused a shift to the right of concentration-response curves for UTP in the h-P-2U-1321N1 cells, and on Schild plots gave a slope different from unity (1.57+/-0.19) and an apparent pA(2) value of 4.32+/-0.13. Suramin was therefore a less potent antagonist at the P-2U-purinoceptor than the P-2Y-purinoceptor. 4 In the presence of the ectonucleotidase inhibitor, ARL 67156 (6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP) there was no significant difference in the EC(50) or shapes of curves with either cell type, and no difference in PA(2) values for suramin. 5 PPADS caused an increase in the EC(50) for 2MeSATP in the t-P-2Y-321N1 cells. The Schild plot had a slope different from unity (0.55+/-0.15) and an X-intercept corresponding to an apparent pA(2) of 5.98+/-0.65. 6 PPADS up to 30 mu M had no effect on the concentration-response curve for UTP with the h-P-2U-1321N1 cells. 7 In conclusion, suramin and PPADS show clear differences in their action at the 2 receptor types, in each case being substantially more effective as an antagonist at the P-2Y-purinoceptor than at the P-2U-purinoceptor. Ectonucleotidase breakdown had little influence on the nature of the responses at the two receptor types, or in their differential sensitivity to suramin.
引用
收藏
页码:704 / 710
页数:7
相关论文
共 40 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   G-PROTEIN-COUPLED P-2 PURINOCEPTORS - FROM MOLECULAR-BIOLOGY TO FUNCTIONAL-RESPONSES [J].
BOARDER, MR ;
WEISMAN, GA ;
TURNER, JT ;
WILKINSON, GF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (04) :133-139
[3]   DIFFERENTIAL-EFFECTS OF P-2-PURINOCEPTOR ANTAGONISTS ON PHOSPHOLIPASE C-COUPLED AND ADENYLYL CYCLASE-COUPLED P-2Y-PURINOCEPTORS [J].
BOYER, JL ;
ZOHN, IE ;
JACOBSON, KA ;
HARDEN, TK .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) :614-620
[4]   NEW STRUCTURAL MOTIF FOR LIGAND-GATED ION CHANNELS DEFINED BY AN IONOTROPIC ATP RECEPTOR [J].
BRAKE, AJ ;
WAGENBACH, MJ ;
JULIUS, D .
NATURE, 1994, 371 (6497) :519-523
[5]   PPADS - AN ANTAGONIST AT ENDOTHELIAL P-2Y-PURINOCEPTORS BUT NOT P-2U-PURINOCEPTORS [J].
BROWN, C ;
TANNA, B ;
BOARDER, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) :2413-2416
[6]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[7]   A P2X PURINOCEPTOR EXPRESSED BY A SUBSET OF SENSORY NEURONS [J].
CHEN, CC ;
AKOPIAN, AN ;
SIVILOTTI, L ;
COLQUHOUN, D ;
BURNSTOCK, G ;
WOOD, JN .
NATURE, 1995, 377 (6548) :428-431
[8]  
COMUNI D, 1995, IN PRESS J BIOL CHEM
[9]   PHARMACOLOGICAL-ANALYSIS AND BIOCHEMICAL-ANALYSIS OF FPL-67156, A NOVEL, SELECTIVE INHIBITOR OF ECTO-ATPASE [J].
CRACK, BE ;
POLLARD, CE ;
BEUKERS, MW ;
ROBERTS, SM ;
HUNT, SF ;
INGALL, AH ;
MCKECHNIE, KCW ;
IJZERMAN, TP ;
LEFF, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) :475-481
[10]  
DANITY IA, 1994, BRIT J PHARMACOL, V112, pP578